FDAnews
www.fdanews.com/articles/70714-mylan-receives-approval-for-generic-accuretic

Mylan Receives Approval for Generic Accuretic

April 5, 2005

The FDA has approved Mylan Pharmaceuticals' abbreviated new drug application for quinapril HCl and hydrochlorothiazide tablets in 10-mg/12.5-mg, 20-mg/12.5-mg and 20-mg/25-mg strengths.

Mylan's drug is the generic equivalent of Pfizer's Accuretic tablets, which are indicated to treat high blood pressure. Pfizer's Accuretic and Accupril had combined sales of approximately $665 million in 2004. The company does not individually list sales of its blood pressure drugs.